Peroxisome proliferator-activated receptor-γ inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 291, Issue 1, 2006, Pages

  Sung, Yong Lee ^a   Eun, Joo Kang ^a   Gyu, Young Hur ^a   Ki, Hwan Jung ^c   Hye, Cheol Jung ^b   Sang, Yeub Lee ^b   Je, Hyeong Kim ^c   Shin, Chol ^c   Kwang, Ho In ^b   Kyung, Ho Kang ^a   Se, Hwa Yoo ^b   Shim, Jae Jeong ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea University   (South Korea)

Author keywords

Epidermal growth factor receptor; Phosphatase and tensin homolog deleted on chromosome 10; Rosiglitazone; Smoking

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CIGARETTE SMOKE; MUCIN; MUCIN 5AC; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CARCINOMA, MUCOEPIDERMOID; CELL LINE, TUMOR; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; HYPOGLYCEMIC AGENTS; LUNG NEOPLASMS; MUCINS; PHOSPHORYLATION; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RESPIRATORY MUCOSA; SMOKING; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE; TYRPHOSTINS;

EID: 33745686056     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00388.2005     Document Type: Article

References (51)

1. Adler KB, Fischer BM, Wright DT, Cohn LA, and Becker S. Interactions between respiratory epithelial cells and cytokines: relationships to lung inflammation. Ann NY Acad Sci 725: 128-145, 1994.
2. Aljada A, Garg R, Ghanim H, Mohanty P, Hamouda W, Assian E, and Dandona P. Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action? J Clin Endocrinol Metab 86: 3250-3256, 2001.
3. Atherton HC, Jones G, and Danahay H. IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation. Am J Physiol Lung Cell Mol Physiol 285: L730-L739, 2003.
4. Backman S, Stambolic V, and Mak T. PTEN function in mammalian cell size regulation. Curr Opin Neurobiol 12: 516-522, 2002.
5. Baeuerle PA and Baltimore D. NF-kappa B: ten years after. Cell 87: 13-20, 1996.
6. Burgel PR and Nadel JA. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 59: 992-996, 2004.
7. Cantley LC. The phosphoinositide 3-kinase pathway. Science 296: 1655-1657, 2002.
8. Cantrell DA. Phosphoinositide 3-kinase signalling pathways. J Cell Sci 114: 1439-1445, 2001.
9. Chan TO, Rittenhouse SE, and Tsichlis PN. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annu Rev Biochem 68: 965-1014, 1999.
10. Chen G and Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635, 2002.
11. Chen R, Lim JH, Jono H, Gu XX, Kim YS, Basbaum CB, Murphy TF, and Li JD. Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF- kappaB signaling pathways. Biochem Biophys Res Commun 324: 1087-1094, 2004.
12. Chung SW, Kang BY, Kim SH, Pak YK, Cho D, Trinchieri G, and Kim TS. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. J Biol Chem 275: 32681-32687, 2000.
13. Cunard R, Ricote M, DiCampli D, Archer DC, Kahn DA, Glass CK, and Kelly CJ. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J Immunol 168: 2795-2802, 2002.
14. Davies MA, Kim SJ, Parikh NU, Dong Z, Bucana CD, and Gallick GE. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clin Cancer Res 8: 1904-1914, 2002.
15. Deshmukh HS, Case LM, Wesselkamper SC, Borchers MT, Martin L, Shertzer HG, Nadel JA, and Leikauf GD. Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. Am J Respir Crit Care Med 171: 305-314, 2005.
16. Desvergne B and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20: 649-688, 1999.
17. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, and Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803-812, 1995.
18. Fruman DA and Cantley LC. Phosphoinositide 3-kinase in immunological systems. Semin Immunol 14: 7-18, 2002.
19. Goetze S, Eilers F, Bungenstock A, Kintscher U, Stawowy P, Blaschke F, Graf K, Law RE, Fleck E, and Grafe M. PPAR activators inhibit endothelial cell migration by targeting Akt. Biochem Biophys Res Commun 293: 1431-1437, 2002.
20. 2 redox stress. Am J Respir Cell Mol Biol 19: 786-798, 1998.
21. Gu J, Tamura M, and Yamada KM. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 143: 1375-1383, 1998.
22. Hlobilkova A, Knillova J, Bartek J, Lukas J, and Kolar Z. The mechanism of action of the tumour suppressor gene PTEN. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147: 19-25, 2003.
23. Hong G, Davis B, Khatoon N, Baker SF, and Brown J. PPAR gamma-dependent anti-inflammatory action of rosiglitazone in human monocytes: suppression of TNF alpha secretion is not mediated by PTEN regulation. Biochem Biophys Res Commun 303: 782-787, 2003.
24. Jones R, Bolduc P, and Reid L. Goblet cell glycoprotein and tracheal gland hypertrophy in rat airways: the effect of tobacco smoke with or without the anti-inflammatory agent phenylmethyloxadiazole. Br J Exp Pathol 54: 229-239, 1973.
25. Kane LP, Shapiro VS, Stokoe D, and Weiss A. Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 9: 601-604, 1999.
26. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, and Waterfield MD. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 17: 615-675, 2001.
27. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, and Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774, 1992.
28. Klingler-Hoffmann M, Bukczynska P, and Tiganis T. Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells. Int J Cancer 105: 331-339, 2003.
29. Kohri K, Ueki IF, and Nadel JA. Neutrophil elastase induces mucin production by ligand-dependent epidermal growth factor receptor activation. Am J Physiol Lung Cell Mol Physiol 283: L531-L540, 2002.
30. Lewis JD, Lichtenstein GR, Stein RB, Deren JJ, Judge TA, Fogt F, Furth EE, Demissie EJ, Hurd LB, Su CG, Keilbaugh SA, Lazar MA, and Wu GD. An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis. Am J Gastroenterol 96: 3323-3328, 2001.
31. Lora JM, Zhang DM, Liao SM, Burwell T, King AM, Barker PA, Singh L, Keaveney M, Morgenstern J, Gutierrez-Ramos JC, Coyle AJ, and Fraser CC. Tumor necrosis factor-alpha triggers mucus production in airway epithelium through an IkappaB kinase beta-dependent mechanism. J Biol Chem 280: 36510-36517, 2005.
32. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, and Tonks NK. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94: 9052-9057, 1997.
33. Nadel JA. Role of epidermal growth factor receptor activation in regulating mucin synthesis. Respir Res 2: 85-89, 2001.
34. Nakajima A, Wada K, Miki H, Kubota N, Nakajima N, Terauchi Y, Ohnishi S, Saubermann LJ, Kadowaki T, Blumberg RS, Nagai R, and Matsuhashi N. Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120: 460-469, 2001.
35. O'Donnell RA, Richter A, Ward J, Angco G, Mehta A, Rousseau K, Swallow DM, Holgate ST, Djukanovic R, Davies DE, and Wilson SJ. Expression of ErbB receptors and mucins in the airways of long term current smokers. Thorax 59: 1032-1040, 2004.
36. O'Mahony A, Lin X, Geleziunas R, and Greene WC. Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions. Mol Cell Biol 20: 1170-1178, 2000.
37. Patel L, Pass I, Coxon P, Downes CP, Smith SA, and Macphee CH. Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol 11: 764-768, 2001.
38. Ricote M, Li AC, Willson TM, Kelly CJ, and Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82, 1998.
39. Rieusset J, Roques M, Bouzakri K, Chevillotte E, and Vidal H. Regulation of p85alpha phosphatidylinositol-3-kinase expression by peroxisome proliferator-activated receptors (PPARs) in human muscle cells. FEBS Lett 502: 98-102, 2001.
40. Rogers DF. Mucus hypersecretion in chronic obstructive pulmonary disease. Novartis Found Symp 234: 65-77, 2001.
41. Shao MX, Nakanaga T, and Nadel JA. Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-α-converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol 287: L420-L427, 2004.
42. Shim JJ, Dabbagh K, Ueki IF, Dao-Pick T, Burgel PR, Takeyama K, Tam DC, and Nadel JA. IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol 280: L134-L140, 2001.
43. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, and Mak TW. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39, 1998.
44. Takeyama K, Dabbagh K, Jeong Shim J, Dao-Pick T, Ueki IF, and Nadel JA. Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol 164: 1546-1552, 2000.
45. Takeyama K, Dabbagh K, Lee HM, Agusti C, Lausier JA, Ueki IF, Grattan KM, and Nadel JA. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 96: 3081-3086, 1999.
46. Takeyama K, Jung B, Shim JJ, Burgel PR, Dao-Pick T, Ueki IF, Protin U, Kroschel P, and Nadel JA. Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol 280: L165-L172, 2001.
47. Von Knethen AA and Brune B. Delayed activation of PPARgamma by LPS and IFN-gamma attenuates the oxidative burst in macrophages. FASEB J 15: 535-544, 2001.
48. West KA, Linnoila IR, Belinsky SA, Harris CC, and Dennis PA. Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3′-kinase/Akt pathway in vitro and in vivo. Cancer Res 64: 446-451, 2004.
49. Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, and Lehmann JM. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem 39: 665-668, 1996.
50. Xia X and Serrero G. Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors. J Cell Physiol 178: 9-16, 1999.
51. Yu CF, Liu ZX, and Cantley LG. ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase. J Biol Chem 277: 19382-19388, 2002.